Items where authors include "Ilett, EJ"

Article

Müller, LME, Migneco, G, Scott, GB et al. (17 more authors) (2021) Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. Journal for ImmunoTherapy of Cancer, 9 (3). e001803. ISSN 2051-1426

Ilett, EJ orcid.org/0000-0002-9875-0322 (2020) Delivery of Oncolytic Reovirus by Cell Carriers. Methods in Molecular Biology (Oncolytic Viruses), 2058. pp. 229-236. ISSN 1064-3745

Berkeley, RA, Steele, LP, Mulder, AA et al. (8 more authors) (2018) Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy. Cancer Immunology Research, 6 (10). pp. 1161-1173. ISSN 2326-6066

Taggart, D, Andreou, T, Scott, KJ orcid.org/0000-0002-5790-9579 et al. (7 more authors) (2018) Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking. Proceedings of the National Academy of Sciences of the United States of America, 115 (7). E1540-E1549. ISSN 0027-8424

Samson, A orcid.org/0000-0002-3081-7850, Scott, KJ orcid.org/0000-0002-5790-9579, Taggart, D et al. (36 more authors) (2018) Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science Translational Medicine, 10 (422). eaam7577. ISSN 1946-6234

Jennings, V, Ilett, EJ orcid.org/0000-0002-9875-0322, Scott, K orcid.org/0000-0002-5790-9579 et al. (10 more authors) (2014) Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International Journal of Cancer, 134 (5). pp. 1091-1101. ISSN 0020-7136